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The objective of this thesis was to further the understanding of the consequences of stress and 
smoking during pregnancy, the causes of intrauterine growth and asthma as well as the 
consequences of asthma on school performance and to explore explanations of observed 
associations. 
In Study I we investigated the associations between four measures of subjective distress and 
cortisol levels in early and late pregnancy and perinatal outcomes. All estimated associations 
were small and most statistically non-significant. However, for birth weight by gestational 
age the estimated associations with subjective distress were statistically significant, indicating 
higher birth weight with higher distress. Results were similar in early and late pregnancy. 
In Study II we explored an intergenerational effect of smoking during pregnancy (SDP) on 
the grandchildren’s intrauterine growth. The grandchildren of maternal grandmothers who 
smoked during pregnancy had a slightly higher risk of being large for gestational age, which 
may be partly explained by a higher obesity rate among their daughters (grandchild’s 
mother). In contrast, the grandchildren of paternal grandmothers who smoked during 
pregnancy had slightly higher risk of being small for gestational age, which may be partly 
explained by a higher SDP rate among their daughters-in-law (grandchild’s mother). 
Sensitivity analysis with regard to unmeasured confounding indicated that this may explain 
the associations. 
In Study III, we explored the association between tobacco use during pregnancy and 
offspring asthma/wheeze and the potential role of nicotine and familial factors such as genes 
and environment shared within the family. We found that SDP was associated with a higher 
risk of asthma/wheeze in the first two years of life, but not at higher ages. Analysis of the 
association between oral snuff use in pregnancy, i.e. exposure to nicotine without combustion 
toxins, and asthma/wheeze indicated no clear association. The sibling comparisons showed 
lower estimates. Taken together this indicates that the role of nicotine in the association 
between SDP and asthma/wheeze may be limited, while familial factors seem important. 
In Study IV we examined if adolescents with asthma in school Grades 7-8 and 9 perform 
worse in school compared to adolescents without asthma. Our results indicated that school 
performance of adolescents with asthma was somewhat better than among those without 
asthma, but also that asthma severity and control were important. Adolescents with severe, 
but controlled asthma, performed somewhat better than those without asthma, while children 
with uncontrolled asthma performed somewhat worse. Sibling analyses indicated familial 
factors explained most associations, with the exception of an association between 
uncontrolled asthma in Grade 9 and slightly lower school performance. 
In conclusion, considering other known detrimental effects of the risk factors investigated in 
this thesis, our findings of no or very modest associations, should not in any way be 
interpreted as excuses for ignoring stress in pregnant women, continue smoking during 
pregnancy or give up the strife for asthma control in children and adolescents.  
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A pregnancy is the start of a new human life and a period filled with expectations for future 
family life, but also of worry about not giving the unborn child the optimal intrauterine 
environment and about the health of the unborn child. Many parents are aware of the 
possibility that life in utero may influence the child’s health both at birth and later in life.  
Worry, stress or depressive mood during the pregnancy may have adverse effects for both the 
foetus and the mother-to-be. One early sign of a child’s wellbeing is its growth in utero, but it 
is also important for the child not to be born too early. Does mothers’ distress during 
pregnancy affect the child’s intrauterine growth or gestational age at birth?  
Although parents-to-be want the best for their unborn child, it may be difficult to live up to all 
expectations and we see that some women are unable to refrain from habits that may hurt the 
child, such as consumption of tobacco and other drugs during the pregnancy. Researchers 
have found evidence of intrauterine life not only influencing the foetus and the newborn, but 
also health in childhood and adulthood. Smoking during pregnancy is known to affect the 
birth weight of the child, but could it also affect the intrauterine growth in the next 
generation? A disease that is believed to be influenced by the intrauterine environment is 
childhood asthma. Tobacco smoke exposure in utero in particular is believed to cause asthma, 
but the mechanism is not clear.  
Asthma may be a life-threatening disease if untreated, but it may also have other more subtle 
consequences. Ability to perform well in school is important for the child’s future and may be 
influenced by asthma symptoms. Thus, understanding the consequences of maternal distress 
and smoking during pregnancy as causes of reduced intrauterine growth, shorter gestational 
age, or asthma, as well as the consequences of childhood asthma is important for parents, 








1.1 DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE 
In 1986 David Barker studied rates of infant death in towns in Britain and mortality due to a 
number of causes in the same towns almost fifty years later. He saw a striking correlation 
between infant death and ischemic heart disease. Based on those results he formulated the 
hypothesis that early life nutrition was important for ischemic heart disease later in life [1]. 
Barker’s hypothesis has been called the foetal or developmental programming hypothesis, 
and more lately, Developmental Origins of Health and Disease (DOHaD). The concept has 
developed to include not only early life nutrition, but all kinds of early life exposures, such as 
chemicals, tobacco smoke, light, stress, and microbiota [2]. 
There is a wide range of studies, both experimental and epidemiological, showing 
associations between early life exposures and health outcomes in later life. However, the 
mechanisms by which those early life exposures may influence outcomes later in life are 
unclear [3]. It could be due to adaptive changes that are valuable for the foetus/child in the 
short run, but which could cause dysfunction or morbidity later in life [4]. Some of these 
adaptive changes could appear through epigenetic modifications including DNA methylation, 
modification of histones and non-coding RNAs. They change the gene regulation without 
changing the DNA sequence and could explain how one genotype can cause different 
phenotypes [5]. However, it is also likely that at least some of the associations seen are due to 
other mechanisms or confounding.  
1.2 STRESS AND DISTRESS 
Hans Selye has been attributed the first description of stress, which was published in the 
1930’s [6]. He described it as ‘the non-specific response of the body to any demand’. 
According to Lazarus' stress-coping model, stress is an environmental demand exceeding a 
person's ability to meet it [7]. There are two components of stress. The first part is a threat 
(stressor) and the second part is the reaction in the body in response to the stressor [7].This 
reaction comes from three biological systems that are related. The neuroendocrine systems 
involved in controlling the stress are the hypothalamic-pituitary-adrenal (HPA) axis and the 
sympathetic-adreno-medullary (SAM) limb of the autonomic nervous system. When exposed 
to a stressor, the sensory systems of the brain evaluate the stressor in relation to the current 
situation and previous experiences. Then, if a challenge to homeostasis is detected, the 
autonomous nervous system is activated which makes the SAM release noradrenaline and 
adrenaline. Noradrenaline and adrenaline increase the blood volume pumped out by the heart 
and raise the blood pressure, moves blood from the gut and skin to the muscles and makes the 
liver release glucose into the blood. At the same time the HPA axis is activated, which causes 
a release of cortisol. This release of cortisol is necessary for the fight-or-flight response [8].  
When quantifying stress, we can either measure the actual stressor, the psychological 
response to the stressor or the biological response to the stressor. Examples of stressors are 
stressful life events, job stress, marital stress, extreme temperatures or noise, which are 
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usually measured by questionnaires or physical measurements. The psychological response is 
the individual’s subjective reactions to stressors and ability to cope [9].  Distress is a broad 
concept covering a wide range of subjective response to stressors, which may include 
depressive symptoms, anxiety and sleep problems [8]. Examples of questionnaires for 
measuring distress are the Perceived Stress Scale (PSS) [10], the Beck Depression Inventory 
[11], the Brief Stress and Coping Inventory [12] and Center for Epidemiologic Studies 
Depression Scale (CES-D) [13]. 
When using the biological approach, stress can be measured as biomarkers, which can be 
regarded as objective measures of stress [9]. A commonly measured stress biomarker is 
cortisol, which varies over the day. It increases the last hours before awakening, with a rather 
steep increase during the first 30 minutes, followed by a decrease over the day and early night 
[14]. Cortisol can be measured in saliva, blood, urine or hair. Samples in both saliva and 
blood capture the daily pattern and the correlation between the two is usually high with a time 
lag of no more than 1-2 minutes [15].  
Although cortisol is a measure of stress response, there are mixed results from studies on the 
correlation between subjective measures of stress and cortisol. The reasons for this may be 
small studies, variation in timing of measurements, differences in study populations and 
stress measures [16]. 
1.2.1 Distress in pregnancy 
Distress during pregnancy is believed to cause preterm labour, low birth weight and 
pregnancy-induced hypertension [17,18]. It may also increase the risk of neuropsychological 
developmental delay, obesity and asthma in the offspring [17,18].  
The mechanism by which maternal distress would affect the foetus is not clear [19]. An early 
observation was a decreased blood flow to the foetus [20], although it has never been 
replicated [21]. Another suggestion is mediation through foetal exposure to elevated cortisol 
levels. Although the placenta works as a barrier which protects the foetus from high levels of 
cortisol, some cortisol crosses the placenta. About 80–90% of the cortisol is inactivated by an 
enzyme (11β-hydroxisteroid dehydrogenase type-2), and converted to biologically inactive 
cortisone when crossing the placenta [19,22]. As a result, the cortisol levels of the foetus are 
only 10-20% of those of the mother. Nevertheless, 30-40% of the variation in the foetal 
cortisol levels may be explained by variation in maternal cortisol levels [19,22]. 
Although mean levels of cortisol increases as pregnancy progresses [23], it has been shown 
that the maternal HPA axis is downregulated during the course of the pregnancy such that the 
cortisol response to acute stressors and awakening decreases [24,25]. It is also possible that 
the foetus could be exposed to elevated levels of cortisol, despite cortisol levels not being 
elevated in the mother, as a result of this downregulation of the HPA axis. This could happen, 
due to changes in the placental function, causing more cortisol passing through the placenta, 
when the mother is stressed [26]. As for results on associations between distress measures 
and cortisol levels in general, statistically significant associations have been found in 
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pregnant women in several studies [27-36], while others found none [37-41]. In studies 
finding statistically significant associations a general pattern has been lower morning cortisol 
levels, flatter diurnal decline and higher evening cortisol levels with higher levels of distress.  
In preparation for Study 1, we identified a knowledge gap. To our knowledge there were no 
studies which had investigated the correlation between subjective distress and cortisol 
measures at different time points during pregnancy, as a way to explore the down regulation 
of the HPA axis.  
1.3 TOBACCO USAGE 
Researchers have identified more than 5300 chemical compounds in cigarette smoke, 
including nicotine, benzene, carbon monoxide, nitric oxide, polycyclic aromatic 
hydrocarbons (PAHs), lead and cadmium [42,43 ]. According to the International Agency for 
Research on Cancer, seventy of the compounds in cigarette smoke have been deemed 
carcinogenic [43]. However, tobacco smokers are not only at increased risk of cancer; 
tobacco smoke is also a major risk factor for cardiovascular and pulmonary diseases and 
adverse pregnancy outcomes [42]. 
Swedish moist oral snuff is a tobacco product which is placed under the upper lip. As it is not 
burnt, snuff users are not exposed to the chemical compounds that come from combustion of 
the tobacco, but they are often exposed to high levels of nicotine [44]. 
1.3.1 Tobacco usage during pregnancy 
Tobacco smoking during pregnancy (SDP) has declined in many countries in the past decades 
[45,46]. In Sweden the prevalence of SDP has decreased from 31% in 1983 to 5.6% in 2013 
(Figure 1) [47]. However, there are large differences between groups, e.g. among pregnant 
teenagers the prevalence of SDP is still >20% at the first antenatal care visit, while it is below 
4% among women of 30 years and above [47]. Other factors that have been identified as 
associated with SDP are low socioeconomic status, parity, marital status, birth 
country/ethnicity and passive smoking [48-50]. Data from the Swedish National Board of 
Health and Welfare on snuff use during pregnancy shows a fairly constant usage of 1.0-1.4% 
from year 2000 to 2013 (Figure 1). 
Despite the reduction in SDP, it is still an important exposure with adverse effects on the 
pregnant woman and her foetus [45,46]. It has been found to be associated with a number of 
complications during the pregnancy, including placenta previa, placental abruption, and 
premature rupture of membranes [51]. Several studies have also found evidence of adverse 
effects in the offspring. Low birth weight and small for gestational age (SGA) are among 
those and it is believed that the exposure causes growth retardation as well as premature birth. 
There is also consistent evidence of associations with perinatal death, cognitive and 
neurobehavioral deficits as well as cleft lip and/or palate in the offspring [42]. Moreover, 
reviews and meta-analyses of epidemiological studies have shown associations between SDP 
and worse lung function and respiratory disorders in the offspring [52-55]. As with SDP, 
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Swedish moist oral snuff use in pregnancy has been linked to increased risk of stillbirth 
[56,57 ], preterm birth [58,59,60 ], lower birth weight [59,61], small for gestational age [62], 
neonatal apnoea [63] and oral cleft malformation [64], but unlike SDP, also to an increased 
risk of preeclampsia [59]. 
  
 
Figure 1. Prevalence of smoking and oral snuff use during pregnancy at first antenatal care visit 1983-2013, 
based on a report from the Swedish National Board of Health and Welfare [47]. 
1.4 PERINATAL OUTCOMES 
1.4.1 Gestational age at birth 
Gestational age at birth is based on an estimate of when conception took place, a time point 
which can be estimated based on either the mother’s reported date of last menstrual period or 
ultrasound measurement of the size of the foetus. Since the 1980’s almost all pregnancies in 
Sweden are dated using ultrasound measurements, usually in weeks 16-20 [47]. Preterm birth 
has been defined by the World Health Organisation (WHO) as birth before 37 full weeks 
from the first day of the woman’s last menstrual period [65]. However, the cut off at 37 
weeks is arbitrary and research has shown that also early term (weeks 37-38) infants are at 
increased risk of some adverse outcomes compared to infants born weeks 39-40 [66-68]. A 
wide range of risk factors for premature birth have been identified, among others low or high 
maternal age, nulliparity, short inter-pregnancy interval, smoking, recreational or illicit drug 
use, male foetus, and a wide range of maternal, placental, uterine and foetal conditions [69]. 
Complications due to premature birth has been deemed the leading cause of neonatal death, 
accounting for 34% of all neonatal deaths worldwide [70]. Preterm birth is also considered a 
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risk factor for worse neurodevelopmental outcomes, higher risk of hospital admission, 
behavioural and learning problems [69].  
1.4.2 Intrauterine growth and birth size 
Two important components influence birth weight (BW) and birth length (BL) – pregnancy 
duration and intrauterine growth. Birth weight and low birth weight (LBW) are often used as 
proxies for intrauterine growth and intrauterine growth restriction (IUGR). IUGR is defined 
as a restraint in growth such that the child does not reach its genetic growth potential. Small 
for gestational age (SGA) is a closer proxy for IUGR. Although many of the infants classified 
as SGA have suffered from IUGR, constitutionally small children may also be classified as 
SGA, as the measure does not take heritability and the growth trajectory into account [71].  
IUGR has been considered important as the affected infants are at increased risk of neonatal 
mortality and early infections [71]. Furthermore, there is evidence of an increased risk of 
childhood disorders such as asthma and neurodevelopmental disorders, and impaired health 
in adulthood e.g. psychiatric disorders, hypertension and insulin resistance among individuals 
born with IUGR, although some of those associations are disputed [71-73].  
There are many factors influencing intrauterine growth – maternal, placental and foetal 
factors. Examples of maternal factors are vascular disorders, pulmonary disease, anaemia and 
smoking [71,74,75]. Genes, multiple gestation and intrauterine infections are among the 
foetal factors that are thought to influence intrauterine growth [71,75]. 
1.4.3 Distress during pregnancy and perinatal outcomes 
Distress during pregnancy has been associated with negative perinatal outcomes such as 
giving birth prematurely or to a child with LBW. A meta-analysis on antenatal stress, 
measured by stress questionnaires or stressful life-events (exposure to bereavement and 
hurricanes), and its association with LBW and preterm birth showed associations with odds 
ratios (OR) in the range 1.42-1.98 [76].  
In a large systematic review focusing on antenatal depression and the associations with 
preterm birth, gestational age (GA), birth weight or LBW, the authors reviewed 50 reports on 
preterm birth or GA and deemed the results inconclusive, while they concluded the results for 
birth weight or LBW (33 reports) were indicative of an association [77]. In contrast, a meta-
analysis study, based on 4-15 reports, found a statistically significant 37% increased odds of 
premature delivery if the mother was depressed, compared to mothers who were not 
depressed, while estimates for GA, LBW and birth weight were all small and statistically 
non-significant [78]. Likewise, Grote et al [79] found depression to be associated with 
preterm birth and LBW, but less so for intrauterine growth restriction. However, their results 
also showed that associations were stronger in developing countries compared to the United 
States and Europe. They also found stronger associations in studies of lower quality. 
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Anxiety was found to be associated with prematurity (pooled ORs: 1.41-1.54) and LBW 
(pooled ORs: 1.76-1.80) in two meta-analysis studies [80,81], while one of the studies also 
showed associations with GA, birth weight and SGA [81].  
Studies on the association between sleep quality and perinatal outcomes are rarer. A meta-
analysis study on sleep, premature birth and LBW included four small studies (338 study 
participants in total) on the association with premature birth and two studies (56 participants) 
on the association with SGA, both including studies with quality issues [82]. They found a 
statistically significant two-fold odds of preterm birth in women with poor sleep quality and 
50% increased odds for SGA, which was not statistically significant. 
The relation between maternal salivary cortisol in pregnancy and birth weight has been 
studied with different cortisol measures and varying findings [22]. The rate of increase in 
cortisol levels during the first 30 minutes after awakening (cortisol awakening response, 
CAR) in early (<27 weeks) pregnancy has been found to be associated with subsequent lower 
BW and BL in the offspring [37]. Likewise, higher morning cortisol values has shown 
statistically significant associations with SGA [83], and lower BW [83,84], but also with 
higher BW [38]. Statistically significant associations has also been found between higher 
evening cortisol levels and SGA [36], shorter gestation [28], lower BL [27] and lower BW 
[28,36,84]. Flatter diurnal slope has been associated with shorter gestation [36], and lower 
birth weight if measured in late pregnancy [28,38,85,86], but not in early pregnancy [85]. 
Cortisol levels at any time of the day has been found to be associated with shorter gestation 
[87,88] and lower BW [88]. Associations have further been found between larger area under 
the cortisol curve and lower birth weight [40,84,89]. 
One small study of 80 pregnant women, 40 with major depressive disorder and 40 without, 
has provided estimates of associations between depression symptom scales, urinary cortisol 
levels and the perinatal outcomes GA and foetal growth and the role of cortisol in the 
associations between depression symptoms and the perinatal outcomes. Their results 
indicated that cortisol levels explained 90% of the negative association between depressive 
symptoms and GA, and 45% of the association with foetal growth [90]. 
Although one study has shown an important role of cortisol in the association between 
depression symptoms and perinatal outcomes, it is still unclear if cortisol levels are 
mediating the associations between distress and offspring’s birth size and gestational age at 
birth. This knowledge gap was identified in preparation for Study I.  
1.4.4 Grandmother’s smoking during pregnancy and grandchild’s birth 
weight 
There has been an interest, not only in the potential effect of maternal smoking during 
pregnancy on the exposed child, but also in the potential effect it may have on the next 
generation. One reason is that maternal SDP may reduce BW in the offspring, and a positive 
association between maternal and offspring BW has been demonstrated repeatedly [91]. 
Thus, one potential causal pathway through which grandmaternal SDP could affect the BW 
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of the grandchild is if the mother’s BW is reduced due to SDP, then her own children may 
also suffer from reduced BW. However, the results from a twin study indicated that the 
association between mother’s and child’s BWs is not causal but rather driven by genetic 
similarity [75], suggesting a causal pathway via maternal BW would be unlikely. Lower BW 
in the grandchild could also be the result if there were a pathway mediated by maternal SDP. 
Another potential pathway stems from evidence that LBW would increase the risk of obesity 
[92], which in turn could affect BW in the next generation offspring. Epigenetic differences 
caused by SDP could give rise to pathways like those mentioned, but also to other pathways. 
From some recent studies there is evidence of such epigenetic changes, in which newborns 
exposed to tobacco smoke in utero had a different methylation pattern than newborns of non-
smoking mothers [93-95] and the differences prevailed until school age [93,94]. It is still 
unknown whether those differences will last into adulthood.  
In 2003 a study by Hyppönen et al was published on grandmaternal smoking during her 
pregnancy and the BW of the grandchild [96]. They assumed a reduction in BW in the 
grandchild since there is a negative association between maternal SDP and offspring BW and 
a positive association between a mother’s own BW and that of her child. The BW of the 
grandchildren of smoking grandmothers was lower in unadjusted analyses, but not in the 
adjusted analyses. A study by Pembrey et al focused on the BW of the children whose 
mothers smoked during pregnancy and the potential effect of the grandmothers’ smoking 
during pregnancy [97]. Once again, there was a reduced BW, although the difference was not 
significant in the adjusted analyses. The same research group also published a study focusing 
on the offspring of non-smoking mothers. In that study, they observed that boys with 
smoking grandmothers generally had higher BW. The difference was smaller among girls. 
[98]. In both those studies, they investigated both maternal and paternal grandmother’s SDP, 
with some difference in point estimates, but no significant effect difference between the two. 
Rillamas-Sun et al divided their study population in two groups depending on the birth year 
of the grandmother [99]. They saw different patterns in the two groups. If the grandmother 
was born before 1929, the difference in BW between grandchildren of smoking and non-
smoking grandmothers was small and not statistically significant. If the grandmother was 
born in 1929-1945, the BW of the grandchildren was statistically significantly higher if the 
grandmother smoked during pregnancy.  
In a study on maternal smoking during pregnancy, an interaction with grandmaternal 
smoking during pregnancy was included. They saw that the association between maternal 
smoking and BW was more pronounced if the grandmother had also smoked during her 
pregnancy. They made no direct comparison between grandchildren of smoking vs non-
smoking grandmothers [100]. However, from their results, it is possible to derive point 
estimates of the mean BWs among grandchildren of smoking grandmothers and among those 
of non-smoking grandmothers. The mean for the grandchildren of smoking grandmothers 
was slightly higher than that of non-smoking grandmothers. 
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In a recent publication on this topic, there was also a higher BW in grandchildren of 
grandmothers who smoked, although not statistically significant [101]. Thus, several studies 
have shown a higher BW in grandchildren of grandmothers smoking during pregnancy 
compared to those of non-smoking grandmothers [98-101]. Two studies found a lower mean 
BW in the grandchildren of the grandmothers who smoked during pregnancy compared to 
those of the non-smoking grandmothers, although that was not seen in adjusted analyses 
[96,97].  
In many of the studies on grandmother’s smoking during pregnancy and her grandchildren’s 
birth size, there is a notion of mediation by maternal factors, but as far as we are aware there 
are no studies clearly distinguishing between confounders and mediators. One exception was 
a study focused on grandmaternal body mass index (BMI) and the association with the 
grandchildren’s BW. They included estimates of the association between grandmaternal SDP 
and BW of the grandchildren with maternal SDP as a potential explanation for the association 
[102].  Thus, based on previous research it is difficult to draw conclusions about potential 
causal pathways in an intergenerational effect of grandmaternal SDP on the BW of their 
grandchildren, a knowledge gap that was identified in preparation for Study II. 
1.5 CHILDHOOD ASTHMA 
Asthma is one of the most common chronic diseases in childhood, with the worldwide 
prevalence estimated to 14% among 13-14 year olds [103]. In a Swedish study on 7-8 years 
old children the proportion who had ever been diagnosed with asthma by a physician was 
7.4%, while 13% had experienced wheezing the past twelve months [104].   
The disease affects the bronchial tubes in the lungs, where there is a chronic inflammation. 
The most typical symptom is wheezing. Other symptoms are breathlessness, chest tightness 
and cough. Triggers can be airborne allergens, respiratory infections, exercise or cold 
weather.  
Risk factors for asthma which have been suggested in the literature include family history of 
asthma, LBW, damp home environment, obesity (both maternal and own), environmental 
tobacco smoke, low socioeconomic status of the parents, parity, maternal SDP and 
respiratory infections [73,105-109]. 
There are two categories of asthma drugs, those used to prevent inflammation and 
exacerbations (controller medication) and those used to treat exacerbations (reliever 
medications). The first choice of controller medication is inhaled corticosteroids (ICS), 
which, if needed, can be combined with long-acting beta2-agonists (LABA) or leukotriene 
receptor agonists (LTRA). Short-acting beta2-agonists (SABA), reliever medication, are used 
to widen the airways in case of an exacerbation. The goal for the treatment is to reach asthma 
control. More recent advances in the treatment of severe asthma, where asthma control has 
been difficult to reach are the so called biological therapies, including omalizumab, 
mepolizumab, reslizumab, benralizumab and dupilumab [110].  
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The Global Initiative for Asthma (GINA) has issued stepwise treatment recommendations for 
increasing levels of severity with the goal of fully controlled disease [111]. The asthma is 
considered fully controlled if the child has asthma symptoms or need reliever medications no 
more than twice weekly, does not wake up at night due to asthma symptoms and experience 
no limitation with regard to activities [111]. According to the European Respiratory Society 
and American Thoracic Society Task Force a patient has severe asthma if he/she needs high 
dose ICS in combination with another controller medication, in order to achieve a controlled 
asthma or if the disease remains uncontrolled despite this treatment [112]. 
1.5.1 Tobacco use in pregnancy as risk factor for childhood asthma 
Reviews and meta-analyses have shown associations between SDP and childhood respiratory 
disorders such as wheezing and asthma [52-55]. To some extent, a causal effect of SDP on 
respiratory disorders are supported by mechanistic animal studies. Sekhon et al [113] found 
nicotine receptors in the lungs of monkey foetuses, which suggest a mechanism involving 
nicotine as the chemical compound involved. They have also shown in an experimental study 
that the foetuses of monkeys infused with nicotine, in amounts comparable to heavy smoking, 
during pregnancy, had lower lung weight and lung volume than foetuses of unexposed 
monkeys. The exposed monkey babies also performed worse on some lung function 
measures [114]. In preparation for Study III we identified a knowledge gap. As far as we 
were aware, there had been no studies yet on nicotine exposure of the foetus due to use of 
products high in nicotine with low levels of other toxins, such as Swedish moist oral snuff, 
and offspring asthma.  
Tobacco smoking and asthma also share potential risk factors, e.g. low socioeconomic status 
and parity. Thus confounding could be an alternative explanation for the associations seen. 
Apart from adjustment for potential known confounders in epidemiological studies, one study 
has addressed the issue of causality by using sibling design. They studied the association 
between SDP and a number of offspring somatic and behavioural outcomes, including asthma 
at 7 years of age. They had a birth cohort with >50 000 children born 1959-1974, including  
7 400 sibling groups of 2-6 siblings. The only statistically significant association they found 
for asthma was with heavy smoking during pregnancy (>20 cigarettes/day) in the full cohort. 
However, the corresponding point estimate in the sibling analysis was higher, but not 
statistically significant, indicating a potential lack of power [115]. A larger sibling study 
could potentially provide more insight in the issue of confounding from family factors. This 
knowledge gap was addressed in the second part of the aim of Study III. 
1.6 SCHOOL PERFORMANCE 
Apart from limiting future educational prospects, school performance in childhood or 
adolescence is associated with general health [116,117], mental health [118,119 ] and 
mortality [116,120] in adulthood. 
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In younger children school performance is often measured as abilities in reading, writing and 
mathematics. In older children or adolescents school grades, test scores, school attendance, 
drop out and eligibility to further education are commonly used educational outcomes. 
Among the factors thought to influence school performance we have parental socioeconomic 
factors [121,122], parental involvement and expectations [123,124], male gender [122,125], 
prematurity [126], the child’s own personality and attitude [127], general cognitive ability 
[124] and neurodevelopmental disorders such as attention deficit hyperactivity disorder 
(ADHD) [128,129].  
Until recently (2018), most children in Sweden began school the year they became seven 
years old and it was compulsory to attend school for nine years (Grade 9). After compulsory 
school, most students apply to upper secondary school (USS). Admittance to USS is based on 
the grades from Grade 9. To be eligible for USS the student needs to pass all three core 
subjects – Swedish, mathematics and English. National tests in those core subjects are given 
in Grade 9, which are important when teachers grade their students. 
1.6.1 Childhood asthma and school performance 
Several studies have shown that compared to children with asthma, in particular severe 
asthma, are more absent from school, which could affect their academic achievements and 
grades [130-132]. Other factors, that may have a detrimental effect on the schooling of 
children with asthma, are acute exacerbations, sleep disturbances or side effects from asthma 
medication. Sometimes parents or teachers believe their children with asthma are too 
vulnerable to take part in particular school activities [133,134]. Further, a child’s school 
performance may be affected by stress induced by having a chronic illness [133].  
The conclusions from two reviews were that the association between asthma and school 
performance is weak or non-existent [130,132].  A more recent meta-analysis showed that 
asthma was associated with lower cognitive function in several domains in childhood, 
including academic achievement, executive functioning and global intellect, compared to 
their healthy peers, [135]. According to a recent Swedish study, based on the BAMSE cohort, 
children with asthma had a higher risk of low school performance compared to children 
without asthma [136]. Considering that the factors in proposed pathways should be more 
prevalent in children with severe or uncontrolled asthma, studies on asthma and school 
performance should include those aspects. It is also well-established that the prevalence of 
ADHD is higher among children with asthma [137-139] and that ADHD is associated with 
poorer school performance [128]. Irani et al conclude that there is a need of research on the 
association between asthma and school performance taking aspects like asthma control and 
ADHD into account [135]. 
It is also well established that school performance of children from families with lower 
socioeconomic background is poorer compared to children from higher socioeconomic 
circumstances [121]. Furthermore, several researchers have found associations between 
family socioeconomic status and asthma [105,108,140]. Taken together this highlights the 
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risk of confounding by ADHD, socioeconomic status and other family factors, when 
estimating the association between asthma and academic achievement. This knowledge gap 
was addressed in Study IV.    
1.7 EPIDEMIOLOGICAL METHODS  
In medical research, the randomised controlled trial is the gold standard for drawing 
conclusions about causality. However, when investigating potential causes of disease, or 
effects of disease, a problem is that we can rarely randomise the exposures of interest, e.g. 
stress, smoking and asthma. Thus, we rely on observational data and consequently we are 
faced with the issue of confounding. 
Using directed acyclic graphs (DAGs) is a way to get an overview of factors that may 
influence the associations of interest [141]. They can be used to guide the decision on what 
factors to adjust for, what not to adjust for and what unavoidable biasing pathways we have 
(e.g. unmeasured confounders). DAGs have been criticised for being too simplistic [142,143], 
thus care is needed when using them. 
1.7.1 Family design in epidemiology 
A common approach to deal with confounding has been to measure and adjust for potential 
confounders in regression models. 
Another approach is to use quasi-experimental designs, i.e. not randomising individuals to 
exposure, but rather use designs that can help us rule out some alternative explanations. 
Family-based quasi-experimental designs utilise the fact that individuals within the same 
family share characteristics that could confound associations of interest [144]. The most 
obvious example is identical twins, who share the same genome as well as intrauterine 
environment and usually childhood environment to a large degree. By comparing outcomes 
in exposure discordant identical twin pairs, the so-called co-twin control design, we can rule 
out confounding factors shared within the pair. However, there are limitations to the co-twin 
control design. One problem is that they sometimes also share the exposure by default, e.g. 
intrauterine exposures, such as SDP and maternal stress. In such situations the twin pairs do 
not contribute with information for co-twin control estimates. Another common problem is 
lack of power, as identical twins are rather rare. Then sibling design is an option, as in the 
study on SDP and offspring asthma by Gilman et al [115]. Siblings do not share as much as 
identical twins, but they still share 50% of the segregating genes and much of the childhood 
environment.  
When using sibling/twin comparison design, we automatically adjust for all shared 
confounders, no matter whether they are measured or not. It should be noticed that we also 
adjust for all shared factors on the causal pathway (mediators). This could be an issue if we 
aim to estimate the total effect of an exposure, i.e. the effect of the exposure irrespective of 




It is also important to consider the effect of measurement error and non-shared confounders. 
Frisell et al [146] have shown that biases due to those issues may be more serious in sibling 
comparison (paired) analyses than in ordinary unpaired analyses. In particular, the attenuation 
of estimates due to measurement error will be larger than in unpaired analyses. They also 
show that if the correlation of the exposure within sibling pairs is larger than the correlation 
of the confounders, then the sibling comparison analysis will be more biased than the 
corresponding unpaired analyses. 
An assumption made in sibling comparison designs is that there are no carry-over effects 
from one sibling to the next, such as the exposure or outcome in the first sibling affects the 
exposure or outcome and vice versa. Some types of carry-over effects are either 
unproblematic or can easily be dealt with, while others are more problematic. Some of the 
more problematic cases can be shown to lead to conservative estimates of the target 
parameter. However, in one situation – when the outcome in one sibling affects the exposure 
in another sibling – it is difficult, or impossible, to determine the direction of the bias [147]. 
In conclusion, sibling comparison design is a powerful tool for causal inference in 
observational studies. Nevertheless, it is important to acknowledge the limitations when 
drawing conclusions from this type of studies, in particular when we see no exposure effect. 
1.7.2 Mediation analysis 
After having identified exposure-outcome associations in epidemiological research, the 
question about potential causal pathways arise. Mediation analysis plays an important role in 
the investigation of such pathways. The aim is typically to explore the total effect of exposure 
on an outcome, the indirect effect, which is the part explained by the pathway via the 
mediator and the direct effect, which is the effect of the exposure on the outcome that is not 
explained by the mediator of interest. A common approach, often called the traditional 
approach, to this issue is to first adjust for potential confounders in e.g. logistic regression 
models, and then to additionally adjust for a potential mediator. With this approach, the 
regression coefficients from the latter model is typically interpreted as the direct effect, and if 
it does not change, compared to the model without the mediator, it is assumed that there is no 
mediation by those mediators. The indirect effect can also be calculated as the difference or 
ratio between the two regression coefficients for the exposure (difference method) [148,149].   
It has been shown that this traditional approach is prone to be biased [148]. Under certain 
assumptions, this is a valid approach, although, when applied, assumptions made are rarely 
discussed. For a causal interpretation five assumptions regarding confounding are made: 1) 
control is made for all exposure-outcome confounding, 2) control is made for all mediator-
outcome confounding, 3) control is made for all exposure-mediator confounding 4) there is 
no mediator-outcome confounder that is affected by the exposure and 5) there is no exposure-
mediator interaction [150]. From Figure 2a, we can understand assumptions 1) – 3) as that we 
control for all C1, C2 and C3 confounders, while assumption 4) is violated in Figure 2b, where 








   
Figure 2. a) Relation between exposure X, mediator M, outcome Y and confounders C1 and C2. b) The same as 
figure a) but with a confounder C2 being affected by the exposure X. Adapted from VanderWeele [149]. 
Moreover, if a logistic regression model is used with the difference method, the interpretation 
of differences between ORs is hampered by the non-collapsibility of the OR. Non-
collapsibility means that the unadjusted (marginal) and adjusted (conditional) ORs are not 
directly comparable [151]. If the outcome is rare, this problem could be ignored, since, in that 
situation, the OR is approximately equal to the risk ratio [149]. However, in cases with a 
common outcome, the non-collapsibility makes it difficult to interpret a situation when the 
marginal and conditional ORs are approximately the same. That could be due to either no 
indirect effect or due to non-collapsibility. 
By means of counterfactual reasoning, researchers within the field of causal inference, have 
highlighted the assumptions underlying the traditional approach and they have also developed 
methods that can deal with situations when some of these assumptions do not hold [149]. 
Within this framework controlled direct effects as well as natural direct and indirect effects 
can be defined [152].  
The controlled direct effect (CDE) is defined as the effect of the exposure when the mediator 
is fixed at a certain value: 
𝐶𝐷𝐸 = 𝐸[𝑌(1,𝑀 = 𝑚) − 𝑌(0,𝑀 = 𝑚)] 
Here Y(x, M = m) is the potential outcome if the exposure = x and the mediator = m. This is a 
measure that may be of interest for public health applications in situations when the mediator 
could be eliminated. However, there is no corresponding indirect effect.  
The natural direct effect (NDE) is the effect the exposure would have had if we could set the 
mediator to what it naturally would have been for each individual if, for example, there was 
no exposure: 
𝑁𝐷𝐸 = 𝐸[𝑌(1,𝑀0) − 𝑌(0,𝑀0)] 
M0 = the value the mediator would have in the absence of exposure. If there is no interaction 
between exposure and mediator the CDE and the NDE will coincide.  
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The indirect effect (NIE) is the hypothetical difference in outcome if the exposure was fixed 
to a certain value, when the mediator has the value it would have had if each individual was 
exposed, compared to what the mediator would have been if they were unexposed. 
𝑁𝐼𝐸 = 𝐸[𝑌(1,𝑀1) − 𝑌(1,𝑀0)] 






2 RESEARCH AIMS 
2.1 STUDY I 
In study I we sought to estimate associations between measures of subjective distress and 
salivary cortisol, and potential differences in associations between early and late pregnancy, 
and their respective associations with perinatal outcomes. We also aimed to explore the role 
of cortisol as a potential mediator in an association between subjective distress and perinatal 
outcomes. 
2.2 STUDY II 
The aim of study II was to estimate the intergenerational association between grandmothers’ 
SDP and the grandchildren’s foetal growth (SGA and LGA). We also aimed to explore if an 
association could be explained by higher frequencies of SDP or obesity in the mothers, i.e. 
the role of maternal SDP and obesity as mediators in the association.   
2.3 STUDY III 
In study III we aimed to explore the role of nicotine and familial confounding in the 
association between tobacco use in pregnancy and offspring asthma. Here Swedish moist oral 
snuff use served as an indicator of exposure to nicotine without the combustion products from 
cigarette smoking. The role of familial confounding in the association between SDP and 
offspring asthma was explored using family design with comparison within families with 
both exposed and unexposed siblings. 
2.4 STUDY IV 
Our aim in study IV was to investigate if children with asthma in Grades 7-8 and Grade 9 
have a worse school performance in Grade 9, in terms of grades, eligibility to upper 
secondary school, and results on national tests in English, mathematics, and Swedish, 
compared to children without asthma. We also aimed to explore the role of asthma severity, 




3 MATERIALS AND METHODS 
In 2007 “The Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) statement” [153] was published in several medical scientific journals, including 
The Lancet, Epidemiology and Journal of Internal Medicine in order to improve the reporting 
of observational studies, with more detailed information published in a subset of those 
journals [154]. Those guidelines have formed the basis in reporting of methods and results in 
all four studies. 
3.1 STUDY DESIGNS 
3.1.1 Study I 
Study 1 was based on a clinical cohort, the Maternal Asthma Events, Stress and Offspring 
(MAESTRO) study of n = 1693 women. A range of factors, including stress, was evaluated at 
two occasions during pregnancy, first in connection to the first antenatal care visit, usually in 
gestational week 8-12 and then again in week 28-32. The women also provided saliva 
samples at both occasions. The women were followed up for the perinatal outcomes BW, BL, 
BW for gestational age and gestational age at birth.  
3.1.2 Study II 
Study II had an intergenerational design. Information on smoking during pregnancy as 
collected by the midwives was retrieved from the Medical Birth Register (MBR) for women 
(G1) who gave birth in 1982-1983. Their children, the parent generation (G2), were followed 
until 2012 for births of children of their own (G3). The cohort consisted of n = 55 118 
children (G3) with information on maternal grandmother’s SDP and n = 37 506 children (G3) 
had information on paternal grandmother’s SDP. 
3.1.3 Study III-IV 
In study III and study IV we used both cohort design and sibling comparison design based on 
national registry data. In study III we included all children registered in the MBR between 1st  
July 2005 and 31st  December 2012 with information on tobacco use during pregnancy n =  
788 508. In study IV we included all children with grades from Grade 9 in the years 2008-
2013, n = 570 595, and retrieved data on asthma diagnoses and asthma medication in Grades 
7-8 and 9. In both studies we identified all differentially exposed sibling pairs within the 
cohorts for sibling comparisons. 
3.2 MATERIALS 
3.2.1 MAESTRO 
The 1693 participants in the MAESTRO study were recruited in early pregnancy through 
eight antenatal care clinics in Stockholm between 2011 and 2014. At their first visit to the 
antenatal care the women were informed about the study by their midwives. If a woman 
agreed to participate she was asked to sign a written informed consent, provide biological 
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samples, answer questionnaires and a subsample of women were invited to do spirometry 
tests. The questionnaires included items on socioeconomic and obstetric background, stress, 
depression symptoms, worry, sleep and asthma. Blood samples were drawn at the antenatal 
care clinic and sampling kits for morning and evening saliva samples were mailed to the 
participants’ home addresses in connection to recruitment and in week 28-32, along with 
sampling instructions. Due to funding and administrative reasons we randomly selected a 
subsample of participants for analysis of salivary cortisol. Women with both a questionnaire 
response and a corresponding saliva sample in either early or late pregnancy (or both) were 
eligible for selection to cortisol analysis.   
3.2.2 National registers 
For study II-IV we used Swedish national register data from the National Board of Health 
and Welfare and Statistics Sweden. Data from the different registries can be linked using the 
Swedish personal identity number (PIN), which is assigned to everybody with the intent to 
stay in Sweden for more than one year [155]. The PIN is unique for each resident. We used 
data from the Medical Birth Register, the National Patient Register and the Prescribed Drug 
Register held by the National Board of Health and Welfare. We also used data from the Total 
Population Register, the nationwide census of 1985, the Longitudinal integrated database for 
health insurance and labour market studies (LISA by Swedish acronym) and the Swedish 
National School Register, which are held by Statistics Sweden. Inclusion in those registers is 
compulsory for all Swedish residents by law. 
3.2.2.1 Medical Birth Register (MBR) 
The Medical Birth Register (MBR) started in 1973 and covers 96-99% of all live births in 
Sweden [156,157]. Pregnancies ending with spontaneous abortions before 23 weeks 
pregnancy (29 weeks until 2007) or induced abortions are not included. The data in the 
register are collected during pregnancy at the antenatal care clinics, which the vast majority 
of pregnant women in Sweden attend. Data around the birth of the child are recorded at 
obstetric units. Examples of data collected by the midwives at the antenatal care clinics are 
maternal weight and height, tobacco usage before and during pregnancy, family situation and 
diseases such as diabetes, lung disease and chronic kidney disease. The obstetric units collect 
data on the delivery, maternal diagnoses as well as anthropometric measures and health status 
of the newborn. Some information is available from 1973 and onwards, while other items has 
been added later, such as smoking during pregnancy which was added in 1982 and Swedish 
oral snuff use was added in 1999. 
3.2.2.2 National Patient Register (NPR) 
The National Patient Register (NPR) [158] started in 1964 and reached full national coverage 
for inpatient visits in 1987. In 1997 day surgery visits were added, while other specialist 
outpatient care was added in 2001, with approximately 80% coverage. Primary care visits are 
not included in the NPR. The register includes data on diagnoses according to the 
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International Classification of Diseases (ICD), non-pharmaceutical interventions, type of 
clinic, whether the visit was planned or unplanned and dates of admission and discharge.  
3.2.2.3 The Swedish Prescribed Drug Register (SPDR) 
The Swedish Prescribed Drug Register (SPDR) includes all prescribed drugs which have 
been dispensed at pharmacies in Sweden since July 1st 2005. In the register the active 
ingredients of the drugs are coded according to Anatomic Therapeutic Chemical 
classification system (ATC). The register also includes brand name, strength, amount 
dispensed, dosage form, dosage text and dates of prescription and dispense. Prescribed drugs 
which are not dispensed by the patient are not included in the register.    
3.2.2.4 Total Population Register (TPR) 
The Total Population Register (TPR) is a register of all Swedish residents from 1968 and 
onwards [159]. The TPR contains information on each resident’s name, address, birthdate, 
biological sex, birth country, citizenship, marital status, migration within the country, 
immigration, emigration and death. 
3.2.2.5 Censuses 
Censuses were performed in Sweden in 1960 and every 5th year from 1970 to 1990 [160]. 
During the censuses each household had to fill out forms about all members of the household, 
including information on education, occupation and employment along with information 
about the living conditions in the household. Data from the censuses are available for 
researchers from Statistics Sweden. 
3.2.2.6 Longitudinal integrated database for health insurance and labour market studies 
(LISA) 
The LISA database started in 1990 as a register for research [160]. It is updated yearly and 
includes information on all residents that are 16 years or older on December 31st each year. 
Examples of data available from LISA are education, occupation, employment or 
unemployment, income, allowances, family relationship, sick leave, disability pension, social 
welfare and socioeconomic information. Most data in LISA is automatically retrieved from 
other registers, including the TPR. 
3.2.2.7 Multi-generation Register (MGR) 
The Multi-generation Register (MGR) [161] is a register containing information on each 
index person’s biological parents and, where applicable, adoptive parents. Index persons are 
all residents who were born in 1932 or later and still alive in 1961. For 97% of all index 
persons born in Sweden the identity of the mother is available and the identity of the father is 
available for 95%. Missing identity of either parents is most common among index persons 
born in the 1930’s as an important reason for missing information is that the parent died 
before the PIN was introduced in 1947 [161]. 
 
26 
3.2.2.8 Swedish National School Register 
Swedish National School Register includes children at all Swedish schools, except schools 
for children with intellectual disability. It contains subject grades, sum or mean of grades and 
information on eligibility to upper secondary school along with results on national tests in 
English, mathematics and Swedish all from Grade 9. Data is available since the school year 
1987/1988 although the grading system has varied over time.  
3.2.3 Variables 
3.2.3.1 Stress and distress 
Measures of stress and distress are mainly used in study I. For subjective distress we had four 
measures, all based on questionnaires.  
The 10-items version of Cohen’s Perceived Stress Scale (PSS-10), which measures the extent 
to which individuals have found their life situation stressful, during the past month 
[10,162,163]. Each item contributes to the total score by 0-4 points, giving a total score in the 
range 0-40 points. A higher score indicates higher stress level. 
‘Worry’ was measured using a single item where the participants were asked to score their 
current degree of worry using a Likert scale from 0 to 10, with higher score indicating more 
worry. 
The Center for Epidemiologic Studies Depression scale (CES-D) [13] was used to measure 
depressive symptoms in the past week, with scores ranging from 0 to 60 points, with higher 
scores reflecting more symptoms.  
As a measure of ‘Sleep quality’ we used a single question: “How do you usually sleep?” This 
question was answered using a Likert scale, 1 = very poorly and 5 = very well. 
For objective stress we used salivary cortisol [164]. Instructions advised the participants to 
take a sample in the morning around 7 am, before having breakfast and brushing their teeth, 
and another sample in the eveing at approximately 9 pm. The actual time of sampling was to 
be written on a form accompanying the Salivette® tubes that were used for the samples and 
they were told to put the samples in the fridge immediately and mail them to Karolinska 
Institutet Biobank the next day. At the biobank the samples were centrifuged for two minutes 
before storage at –20°C. The samples were analyzed for cortisol levels, using the 
standardized CORT-CT2 radioimmunoassay kit (Cisbio Bioassays, Codolet, France). For 
statistical analyses we used the actual morning and evening cortisol levels with logarithmic 
transformation and the diurnal slope calculated as (morning level – evening level)/(time 
difference between samples in hours). 
All measures of stress and distress were measured at recruitment in early pregnancy and all, 
except sleep quality, were repeated in late pregnancy (week 28-32). 
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3.2.3.2 Tobacco usage during pregnancy 
Information on SDP and Swedish moist oral snuff use was collected from the MBR. Smoking 
information has been recorded in the MBR since 1982-1983. The pregnant women are asked 
about their tobacco habits at the first antenatal care visit (usually in week 8-12). They are 
asked about their current tobacco habits and, since 1999, about their habits three months prior 
to the visit. Since 1990, the women are asked again about their present tobacco habits at a 
visit around week 30-32. Smoking is registered as no smoking, 1-9 cigarettes/day and ≥ 10 
cigarettes/day. Since 1999 tobacco habits also include Swedish moist oral snuff use (yes or 
no). 
For study II we only had information about smoking at the time of the first antenatal care 
visit. For study III data was available for all tobacco habit questions which allowed us to use 
more refined definitions of tobacco use: 
• ‘Smoking in early pregnancy’ was defined as affirmative answers to smoking both at 
the time of the first antenatal care visit and 3 months earlier vs answering no to both 
questions. 
• ‘Still smoking in late pregnancy’ was defined as affirmative answer to smoking at all 
three occasions vs negative answers at all three time points. 
• ‘Smoking before or in very early pregnancy’ was defined as an affirmative answer to 
smoking 3 months before the first antenatal care visit, but negative answer to smoking 
at the time of the first visit vs negative answers to smoking at both those time points. 
• ‘Moist oral snuff use’ was defined as affirmative answers to snuff use both at the time 
of the first antenatal care visit and 3 months earlier vs negative answers regarding 
snuff use at both time points. 
3.2.3.3 Perinatal outcomes 
BW, BL, GA, SGA and LGA were all recorded at birth and retrieved from the MBR. For the 
vast majority (98%) of pregnant women in Sweden, foetal ultrasound is used for pregnancy 
dating of gestational age. If no ultrasound is done, date of last menstruation is used.  
BW for gestational age (BW Z-score) as a continuous measure was calculated using BW, GA 
and sex based on reference curves for intra uterine growth by gestational age, which are 
based on foetal weights estimated by ultrasound and assuming a standard deviation (SD) of 
12% of the mean [165]. The same reference curves are used for SGA and LGA in the MBR, 
where SGA is defined as a BW > 2 SD below the mean curve and LGA as BW > 2 SD above 
the mean curve, thus approximately corresponding to the 2.5th and 97.5th percentile, 
respectively.  
We defined LBW in accordance with the WHO as a weight < 2 500 grams [65], while we 
applied a commonly used cut off for high birth weight (HBW), > 4 500 grams. 
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3.2.3.4 Childhood asthma 
Our asthma variables were based on records of dispensed asthma medications in the SPDR 
and asthma diagnoses in the NPR in accordance with a validation study [166]. As a basis for 
all our asthma definitions we had the following three criteria: 
1) ≥ 2 dispenses of asthma control medication, ICS (ATC: R03BA), LTRA (ATC: 
R03DC03) or combinations of ICS and LABA (ATC: R03AK) or 
2) ≥ 3 dispenses of control medication and/or SABA (ATC: R03AC02–03, R03AC12–
13) in the SPDR within 12 months or 
3) ≥ 1 hospital visit with an asthma diagnosis recorded in the NPR (ICD-10: J45-J46). 
For children below 4.5 years of age ‘asthma ever’ was defined as fulfilling either criteria 1) 
or 2) in combination with criteria 3). For children above 4.5 years ‘asthma ever’ was defined 
as fulfilling any of the three criteria. Time of onset was defined as the date of the first 
prescription of asthma medication or first asthma diagnosis in the NPR, whichever occurred 
first. 
‘Current asthma’ at a certain age was defined as fulfilling the criteria for ‘asthma ever’ in 
combination with having at least one dispense of asthma medication in the SPDR or one 
record with an asthma diagnosis in the NPR at that age. 
For ‘asthma in Grade 7-8’ and ‘asthma in Grade 9’ we required any of the three asthma 
criteria to be fulfilled while being in Grade 7-8 and Grade 9, respectively, including time 
from July 1st the year the child started each grade until June 30th the year the child finished 
the grade. 
Our definition of ‘severe asthma’ was chosen to align as far as possible with the 
corresponding treatment steps of GINA [111]. To be defined as ‘severe asthma’ an average 
daily dose of ICS corresponding to a medium dose or more for children ≥ 12 years old, as 
defined by GINA, was required, plus one (or more) other type of control medication. The 
average daily dose was defined as the total amount of ICS dispensed during the time interval 
divided by the length of the time interval in days. An asthma not deemed to be ‘severe 
asthma’ was classified as ‘mild/moderate asthma’. 
‘Uncontrolled asthma’ in Grade 7-8 was defined as having > 8 dispenses of SABA in total in 
the SPDR during those two years or at least one unplanned hospital visit with an asthma 
diagnosis recorded in the NPR in the same time, while ‘uncontrolled asthma’ in Grade 9 was 
defined as having > 4 dispenses of SABA or an unplanned hospital visit with an asthma 
diagnosis during Grade 9.  
‘Severe asthma’ and ‘uncontrolled asthma’ were combined into an asthma severity and 
control variable with the categories ‘no asthma’, ‘mild/moderate controlled’, ‘mild/moderate 
uncontrolled’, ‘severe controlled’ and ‘severe uncontrolled’. 
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3.2.3.5 School performance 
‘Grade point sum’ from Grade 9 was the sum of all 16 subject grades. Each subject 
contributes with 0-20 points, giving a range of 0-320. 
‘Non-eligibility for USS’ was defined as failing (0 points) in any of three core subjects: 
Swedish, Mathematics and English.  
Results from national tests in the three core subjects was used as a measure of school 
performance that is sensitive to the student’s performance in one particular day. The test 
results range from 0–20.  
3.2.3.6 Other variables 
Other variables that were retrieved from the MBR were birth year of the child, parity, 
maternal height and weight for calculation of BMI, maternal age at delivery and family 
situation (mother living with the father or not during pregnancy). 
Family members (parents and siblings) were identified using the MGR and gender, birth date 
and birth country were retrieved from the TPR.  
Asthma in each parent was defined in the same way as for a child above 4.5 years, although 
with the addition of diagnostic codes in the NPR from earlier ICD-versions (ICD-7:241, ICD-
8:493, ICD-9:493).  
Socioeconomic variables for the parents were retrieved from questionnaires for the study 
based on the MAESTRO cohort and from the censuses and LISA for the register-based 
studies. Thus, we retrieved immigrant status, education, work situation (employed/self-
employed, student, other) and cohabitation with partner from the MAESTRO questionnaires. 
Immigrant status and education was collected in early pregnancy only, while information on 
work situation and cohabitation with partner were collected in both early and late pregnancy. 
For the register-based studies we retrieved socioeconomic index (SEI) from the census in 
1985. Parental education and disposable income, at birth or at the time of the school start of 
the child, were retrieved from the LISA database. 
ADHD was defined as having an ADHD diagnosis registered in the NPR (ICD-10: F90) or 
having dispensed ADHD medication (ATC codes: N06BA01, N06BA04, N06BA09) in the 
SPDR, in accordance with a validation study [167]. 
3.2.3.7 Variables by study 
The variables used in each study as exposure, outcome, mediator and confounders are 
outlined in Table 1.   
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Table 1. Exposure, outcome, mediator and confounder variables by study 











Birth weight Z-scores 
Age at delivery 
BMI 
Parity 
















(G1) and mother (G2): 








Mother (G2) only: 
Education 
III Main exposures: 
‘Smoking in early pregnancy’ 
‘Moist oral snuff use’ 
Other exposures: 
‘Still smoking in late 
pregnancy’ 




Asthma at ages 2, 3, 4, 5 
and 6 years 
Mother only: 











IV Asthma in Grade 7-8 
Asthma in Grade 9 
Asthma severity and control 
in Grade 7-8 
Asthma severity and control 
in Grade 9 
 
Grade point sum 
Non-eligibility for USS 















3.3 STATISTICAL METHODS  
In all four studies we used DAGs to select confounders (see Table 1). We presented results 
from both unadjusted models and models with adjustment for those selected confounders in 
accordance with the STROBE statement [153].  
3.3.1 Study I 
In study I all associations were estimated using linear regression analysis. The estimates were 
adjusted for confounders in accordance with Table 1, except the estimations of associations 
between subjective distress and cortisol, which were adjusted for a subset of the confounders 
– maternal age and BMI. As the actual time for taking the saliva sample was an important 
correlate of cortisol level in the sample, we adjusted for this in all analyses using cortisol 
data, despite not being identified as a confounder. We presented regression coefficients (β) 
and corresponding 95% confidence intervals (CI) for all associations, except those with log 
morning/evening cortisol levels as dependent variables. For those we presented the 
exponentiated regression coefficients, Exp(β), with corresponding 95% CI. Exp(β) is 
interpreted as the ratio between geometric mean cortisol levels corresponding to an increase 
of one unit in the explanatory variable. We also aimed to perform mediation analysis with 
cortisol levels as a mediator in the association between subjective distress measures and 
perinatal outcomes.  
3.3.2 Study II 
The first step of the analyses was to estimate all bivariate associations between SDP, 
underweight and obesity in one generation and SGA, LGA, SDP, underweight and obesity in 
the next generation. We also estimated the associations within generation two (G2), the 
mothers, between their own SGA/LGA and their SDP/underweight/obesity when being 
pregnant. All analyses were adjusted for grandmaternal (generation one, G1) confounders in 
Table 1, while associations between G2 and generation three (G3) were additionally adjusted 
for the G2 confounders in Table 1. All those associations were estimated using logistic 
regression. Logistic regression was also used to estimate the associations between 
grandmaternal (G1) SDP and SGA/LGA in the grandchild (G3) as an estimate of the total 
effect, adjusting for G1 confounders.  
In mediation analyses we estimated total effects, natural direct and indirect effects (NDE and 
NIE) as defined in section 2.7.2, using the SAS macro mediation developed by Valeri et al 
[152]. Both mediators and outcome variables were modelled with the logit link, allowing for 
exposure-mediator interaction. The mediation analyses were adjusted for all G1 (exposure-
outcome) and G2 (mediator-outcome) confounders in Table 1. We performed separate 
analyses for maternal and paternal grandmother’s SDP.  
As unmeasured confounding could be an issue, sensitivity analyses were performed using E-
values. We calculated E-values for both total effects [168] and indirect effects [169] using the 
observed OR (ORobs) as  
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E-value = 𝑂𝑅𝑜𝑏𝑠 +√𝑂𝑅𝑜𝑏𝑠 × (𝑂𝑅𝑜𝑏𝑠 − 1) 
The E-value for the total effect is a measure of the strength, in terms of ORs, of the 
associations between the unmeasured confounder(s) and each of the exposure and outcome 
that would be required to give rise to an OR as that observed, if the true association was null.  
The E-value for the indirect effect is the corresponding associations required for the 
unmeasured confounder(s) of the mediator – outcome association, to give rise to the observed 
OR for the indirect effect, in a situation with no true mediation.  
The secondary outcomes LBW and HBW were analysed in the same way, and the results 
were presented as supplemental material (Appendix II). 
3.3.3 Study III 
We analysed the association between tobacco use during pregnancy and offspring 
asthma/wheeze incidence, with flexible parametric models for time-to-event data with 
attained age as time scale, using the Stata package stpm2 [170]. Follow-up started on the day 
the child was discharged from hospital after birth and ended at the date of asthma/wheeze 
onset, date of first emigration, date of death or 31 December 2013 for children with attained 
age <4.5 years and 31 December 2015 for older children, whichever came first. For the 
flexible parametric model, we used restricted cubic splines with six knots to model the 
baseline hazard. We allowed the hazard ratio (HR) to vary with time (age), again, using 
restricted cubic splines with six knots. Sensitivity analyses were performed with both higher 
and lower number of knots. We presented the results graphically with HR curves by age with 
95% CI curves. As a comparison with the sibling analyses described below, we additionally 
used piecewise constant cox proportional hazards models allowing for different HRs in the 
age intervals 0-365 days, 366-730 days and ≥731 days. All models were adjusted for the 
confounders outlined in Table 1, modelled as time-varying effects in the same way as the 
exposure variables.  
The associations between tobacco use during pregnancy and current asthma at the ages 2-6 
years were analysed using logistic regression and adjusted for the same covariates as the 
time-to-event analyses.  
We explored the role of unmeasured familial factors, using a sibling comparison approach. 
The sibling comparisons included all SDP exposure discordant full sibling pairs in the study 
population. Sibling comparisons account for all genetic environmental confounders and 
mediators, shared within the sibling pairs, including environmental tobacco smoke (ETS), if 
shared by the siblings. If the mother smoked in the pregnancy with a younger sibling, the 
older siblings may be exposed to ETS, which would constitute a carry-over effect in the 
sibling analyses. This was accounted for by including an interaction term between sibling 
order and exposure in all sibling analyses [147]. We used Cox proportional hazards model 
stratified on sibling pairs, assuming piecewise constant hazards in the age intervals 0-365 
days, 366-730 days and ≥731 days, for asthma incidence and conditional logistic regression 
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for current asthma at ages 2 and 3 years. In the sibling analyses we used the covariates birth 
year, parity, maternal BMI and maternal age, as those would differ between siblings and 
robust standard errors were used to account for clustering of sibling pairs within families.  
3.3.4 Study IV 
In study IV we used linear regression analysis to estimate the associations between asthma 
and grade point sum and results of national test in the full cohort. Logistic regression was 
used for the associations between asthma and non-eligibility for USS. Residual distributions 
from the linear regression analyses were slightly skewed, we therefore used robust standard 
errors. The analyses in the full cohort included adjustment for the confounders in accordance 
with Table 1. 
In the sibling comparisons, we included all full sibling pairs and we used fixed effects linear 
regression for the outcomes grade point sum and national test results, although only asthma 
discordant pairs contributed with information for the estimates of interest. Non-eligibility for 
USS was analysed using conditional logistic regression. As covariates we only used factors 
that are likely to differ between siblings, i.e. ADHD and family income the year the child 
started school. Cluster robust standard errors were used to account for clustering of multiple 
sibling pairs within families. 
To help evaluating effect sizes from linear regression analyses, we calculated Cohen’s d = 
β/SD, with β = regression coefficient and SD = standard deviation in the study population. 
Effect sizes can be categorized as small (d ≥ 0.20), medium (d ≥0.50) and large (d ≥ 0.80) 
[171]. 
3.4 ETHICAL ASPECTS 
In 1964 the World Medical Association agreed on ethical principles to be followed in 
research involving humans – the Helsinki Declaration [172]. Those ethical principles are 
there to protect the participants in research projects from injury – physical, mental or breach 
of their integrity. No scientific journals should publish research which does not adhere to the 
Helsinki Declaration. The document is not legally binding in itself, but it has been codified in 
regional or national legislation. The Swedish legislation incorporates principles of the 
Helsinki Declaration in the Ethical Review Act (2003:460), the Public Access and Secrecy 
Act (2009:400) and the Personal Data Act (1998:204), which was replaced by the EU 
directive the General Data Protection Regulation (GDPR) on May 25 2018. The Ethical 
Review Act states that research involving sensitive personal data, physical procedures in 
humans or biological samples from humans may only be performed if permission has been 
granted by the Swedish Ethical Review Authority (previously Regional Ethical Review 
Boards). The Ethical Review Authority weights the potential risk or harm for the study 
individual against the potential benefits of new knowledge. As a general rule the study 
participant has to be informed about the overarching study plan, aims, methods to be used, 
potential risks involved, who is responsible for the study, that participation is voluntary and 
that the participant can withdraw from the study at any time. Once informed the study 
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participant has to consent to participation in order to be included in the study (informed 
consent). This procedure was followed in study I, where biological samples were taken. In 
studies II-IV no physical procedures or other contact involving the participants were 
performed, therefore the Ethical Review Authority granted permission to perform the studies 
without informed consent. All four studies involved processing of sensitive personal data. For 
study I, data was retrieved by questionnaires, analysis of biological samples and linkage to 
register data, while studies II-IV was based on register data only. When ordering register data 
for a research project from the National Board of Health and Welfare and Statistics Sweden 
permission from the Ethical Review Authority is needed. The register holders make a secrecy 
examination, based on the ethical approval, where they determine if data can be disclosed. In 
particular they evaluate if all the ordered data is necessary to complete the research project. If 
the authorities decide they can disclose the data ordered, the data is pseudonymised, i.e. fields 
with personal identifiers are replaced by an artificial identifier to protect the integrity of the 
study participants, unless personal identification is necessary for the research project. After 
receiving the data for the studies in this thesis, it was uploaded in a database to which access 
is granted only to researchers needing the access to perform data management or analysis for 






4.1 STUDY I 
Of the n = 1693 women who were recruited we received complete answers for the 
questionnaire-based distress measures from n = 1055 to n = 1134 participants in early 
pregnancy and n = 880 (the same for all distress measures) in late pregnancy. We had cortisol 
measurements for n = 894 participants in early pregnancy and n = 682 in late pregnancy. 
All the estimated associations between subjective measures of distress and cortisol levels 
were close to null and non-significant (Figure 2).  
 
Figure 2. Regression coefficients with 95% confidence intervals for associations between subjective measures of 
distress and cortisol measures (morning level, evening level and diurnal slope), adjusted for confounders. 
 
Associations between measures of distress in early and late pregnancy and perinatal outcomes 
are displayed in Figure 3. As with the associations between subjective distress and cortisol, 
most associations are close to zero and non-significant, no matter when in pregnancy distress 
was measured. The only exceptions are the estimates of the associations between most of the 
subjective measures of distress and BW Z-scores by gestational age and sex. Those estimates 
were also small, but statistically significant, indicating slightly higher BW Z-scores with 
higher levels of distress, and similar results were found for distress measured in early and late 
pregnancy. As an example, the children of women with PSS-10 levels corresponding to the 




Figure 3. Regression coefficients and 95% confidence intervals estimating the association between subjective 
distress, salivary cortisol and perinatal outcomes, with the outcome in standard deviation units. BW = birth 
weight, BL = birth length, BW Z-scores = birth weight by gestational age and sex, GA = gestational age at birth. 
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heavier than the children of women having a stress level corresponding to the PSS-10 median 
= 14. 
As the associations with cortisol levels were close to null, we could not proceed as planned 
with mediation analyses considering cortisol levels as mediator in the associations between 
subjective stress and perinatal outcomes. More details on Study I are found in Appendix I. 
4.2 STUDY II 
Children (G3) with maternal grandmothers (G1) who smoked during pregnancy were at 
higher risk of LGA than children with non-smoking maternal grandmothers, adjusted OR = 
1.32 (95% CI: 1.16, 1.50), but not at higher risk of SGA (ORadj = 0.92, 95% CI: 0.77, 1.09). 
In contrast, children with paternal grandmothers who smoked during pregnancy were at 
higher risk of SGA (ORadj = 1.19, 95% CI: 1.00, 1.41) but not LGA (ORadj = 1.05, 95% CI: 
0.93, 1.20). More details regarding bivariate associations are found in Study II, Appendix II, 
tables 2, s1 and s2. 
Considering that there was an increased risk of LGA, but not SGA, maternal (G2) obesity 
could potentially explain part of the association, but not maternal SDP, as SDP would 
increase the risk of SGA rather than LGA. Results from the mediation analyses are shown in 
Table 2. Those results indicated that the association between maternal grandmother’s SDP 
and grandchild being born LGA was to a modest part explained by mediation by maternal 
(G2) obesity, with an OR = 1.05 (95% CI: 1.03, 1.06) for the indirect effect. In contrast, there 
was an increased risk of SGA in the grandchildren of paternal grandmothers who smoked 
during pregnancy, thus maternal (G2) SDP could potentially explain the association, while 
maternal obesity would be unlikely to explain the association. The mediation analysis showed 
that a small part of the association between paternal grandmother’s SDP and the grandchild 
being born SGA may be explained by maternal (G2) SDP, with OR = 1.03 (95% CI: 1.01, 
1.05) for the indirect effect (Table 2).  
Table 2. Mediation analysis with maternal and paternal grandmother’s (G1) smoking during pregnancy (SDP) as 
exposure, maternal (G2) obesity and SDP as mediators and grandchild’s (G3) birthweight as outcome, including 





Total effect Direct effect Indirect effect E-value 




  Exposure: Maternal grandmother’s SDP (G1)   
LGA Obesity 1.33 (1.17, 1.51) 1.27 (1.11, 1.44) 1.05 (1.03, 1.06) 1.98 1.27 
  
Exposure: Paternal grandmother’s SDP (G1)   
SGA SDP 1.26 (1.02, 1.56) 1.23 (0.99, 1.52) 1.03 (1.01, 1.05) 1.84 1.21 
SGA = small for gestational age, LGA = large for gestational age 
1 Odds ratios (OR) adjusted for grandmother’s (G1) birth country, socioeconomic index, family situation, BMI, 
age at delivery and parity and maternal (G2) family situation, parity, age at delivery and education 
 
The E-values showed that it would suffice with ORs around two for the associations of 
unmeasured confounders with both grandmaternal SDP and grandchild being born SGA or 
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LGA to give rise to our observed total effects. For the indirect effects the corresponding ORs 
for unmeasured mediator-outcome confounders were 1.21 and 1.27. More details on Study II 
are found in Appendix II. 
4.3 STUDY III 
In the cohort 6.2% of the mothers smoked in early pregnancy and 0.9% used Swedish moist 
oral snuff. The mean time of follow-up was 6.0 years, summing up to 4.7 million person-
years. Results of asthma incidence allowing for time-varying HRs are displayed in Figure 4 
for smoking in early pregnancy and snuff use in early pregnancy, both unadjusted and 
adjusted for the confounders outlined in Table 1. For smoking in early pregnancy, the HR 
increase from birth until a peak around five months of age. Around the age of twelve months 
the HRs increase again and reach a second peak around the age of 18 months. The estimates 
were clearly attenuated with adjustment for confounders, but the bimodality was still there. 
The association between maternal snuff use and offspring asthma incidence showed lower 
HRs and a less distinct pattern, although with a potential association around 1-2 years of age 
and, as with smoking, the estimates were attenuated when adjusting for confounders.  
 
Figure 4. Hazard ratio curves with confidence intervals from flexible parametric models for the association 






Figure 5. Associations between tobacco use in early pregnancy and current asthma at ages 2-6 years. Figure 




Results for current asthma at ages two to six years showed a pattern of diminishing 
associations with smoking in early pregnancy with higher age, which were clearly attenuated 
when adjusted for confounders (Figure 5). For snuff use in early pregnancy the estimated 
associations were small and statistically non-significant at all ages in adjusted analyses. In the 
sibling analyses for smoking in early pregnancy the point estimates showed no increased risk 
of asthma, although the confidence intervals were wide. 
The Cox proportional hazards regressions showed results in line with the flexible parametric 
models in terms of estimates and the results for the sibling analyses using Cox regression 
were similar to those from the sibling analyses for current asthma, more details of Study III 
[173] are found in Appendix III. 
4.4 STUDY IV 
There were n = 31 173 (5.5%) children with asthma in Grades 7–8 and n = 19 467 (3.4%) 
children had asthma in Grade 9. In the study population the mean grade point sum was 213 
(SD = 62) and 8.9% were non-eligible to USS. Children with asthma in Grades 7-8 had on 
average 3.9 (95% CI: 3.3, 4.5) points better grade point sum than children without asthma, 
corresponding to a Cohen’s d = 0.06, adjusted for confounders in accordance with Table 1, 
and they had a slightly lower odds for being non-eligible to USS (ORadj = 0.84, 95% CI: 0.80, 
0.88). When also adjusting for familial factors, by means of sibling comparisons, the 
corresponding difference in grade point sum was 0.4 points (95% CI: -0.6, 1.5) and OR for 
non-eligibility to USS was 0.99 (95% CI: 0.87, 1.12). For asthma in Grade 9 the results were 
similar for the associations with grade point sum and non-eligibility to USS [174].  
When categorising asthma by severity and control we saw that children with controlled 
asthma had slightly better grades (Figure 6) and lower risk of being non-eligible to USS 
(Figure 7), for asthma in both Grades 7-8 and Grade 9, when adjusting for measured 
confounders, while children with mild/moderate uncontrolled asthma had slightly lower 
grade point sum and slightly higher risk of non-eligibility to USS. For controlled asthma 
estimates from sibling analyses were close to null, except for the associations with severe 
controlled asthma in Grades 7-8, indicating slightly better grades among those children. For 
mild/moderate uncontrolled asthma differences remained for asthma status measured in 
Grade 9, but not Grades 7-8.  
Regarding associations with national test results a similar pattern was seen with slightly better 
results for children with severe controlled asthma and slightly worse for children with 
uncontrolled asthma compared to children without asthma. In sibling comparisons, estimates 
for controlled asthma were close to null, while those for uncontrolled asthma were slightly 
lower than for children without asthma, although statistically significant only for national test 
results in English for children with mild/moderate uncontrolled asthma compared to no 





Figure 6. Regression coefficients with 95% CI for associations between asthma and grade point sum by severity 
and control in Grades 7-8 and Grade 9. 
 
Figure 7. Odds ratios with 95% CI for associations between asthma and non-eligibility to USS by severity and 




5.1 METHODOLOGICAL CONSIDERATIONS 
5.1.1 External validity or generalizability 
External validity or generalizability to the target population is an important aspect of 
epidemiological research. This does not necessarily mean that the study population needs to 
be representative of the target population [175]. In Study I the mothers had lower BMI, 
higher education and lower SDP prevalence than the general population of pregnant women, 
indicating a more health conscious study population than the background population.  
However, our analyses were adjusted for socioeconomic factors, age and BMI, and the study 
population may bring the advantage of providing accurate information on health-related 
questions. In Study II, where we studied grandmaternal SDP, the mothers could be born no 
earlier than 1982 to have information on intrauterine exposure to SDP and follow-up for child 
births ended by year 2012. Consequently, the mothers (generation 2) had to give birth to a 
child by 30 years of age and as a result the findings may not be generalizable to a population 
of older mothers, if the biological pathways change with age. In Study III on tobacco use 
during pregnancy and offspring asthma/wheeze, our study population was selected from 
population-based registers, with the main restriction being availability of information on 
tobacco use, where we had 7% non-response. The mechanism leading to non-response is 
either the midwife failing to ask about tobacco usage or the pregnant woman refusing to 
answer, with the former being less problematic with regard to external validity. In Study IV 
on asthma and school performance the main obstacle to the external validity was the 
inclusion criteria requiring grades from Grade 9. However, complete absence of grades in the 
register is unlikely to be due to asthma. 
5.1.2 Selection bias 
Selection bias is related to external validity. If the study population is different from the target 
population, it may be a case of conditioning on a common effect of two factors that differ 
between the two populations. If one of those factors is the outcome or a cause of the outcome 
and the other factor is the exposure (or a cause of the exposure), selection bias occurs [176].  
This could not be ruled out in Study I and II. In Study I we had a selection of women with 
higher education and lower BMI than the target population, where education is likely to 
influence stress levels and BMI is likely to influence intrauterine growth. Selection bias was 
also a potential problem in Study II, where the mothers, the second generation, could be no 
older than 30 years. Maternal age can be influenced by childhood socioeconomic status, 
which may also influence the grandmother’s choice of SDP at the same time as it may be 
influenced by the mother’s own socioeconomic status, which in turn may affect the 
grandchild’s BW. In Study I we could adjust for education and BMI and in Study II we could 
adjust for socioeconomic status. However, we cannot completely preclude bias via other 
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unmeasured lifestyle factors not captured by education and BMI in Study I and 
socioeconomic status in Study II.  
5.1.3 Misclassification and measurement error 
Misclassification of exposure or outcome may bias association estimates. Misclassification 
can either be differential, i.e. differ between exposure groups or by outcome, or non-
differential. Differential misclassification would lead to under- or overestimation of 
associations, depending on patterns of misclassification. Non-differential misclassification of 
the exposure would most likely lead to bias towards the null, while non-differential 
misclassification of the outcome would most often lead to lower precision in the estimates 
and thereby reduced power.  
Two of our measures of distress in Study I, PSS-10 and CES-D, are psychometric scales 
considered to have high validity and are recommended for use in the general population and 
for pregnant women [13,162,163]. Worry and sleep quality have not been validated, but they 
all showed similar patterns of associations with the outcome as PSS-10 and CES-D. Salivary 
cortisol has the advantage of capturing the variations over the day, although that also carries 
the disadvantage of higher variability, as compared to cortisol measured in urine or hair. In 
order to reduce variability, study participants were asked to sample saliva at certain times in 
the morning and the evening. Although many followed the instructions some failed to do so, 
but the time of sampling was noted and the analyses were adjusted for the actual sampling 
time. Nevertheless, we could not exclude some attenuation of the estimates due to variation in 
sampling time. 
Tobacco habits during pregnancy were reported by the pregnant women to the midwives 
when visiting the antenatal care clinics. As always with health hazardous behavior there is a 
risk of the women not answering truthfully. However, validation studies based on cotinine 
measurements with and without the women’s knowledge has shown a good concordance 
between reported tobacco habits in the MBR and cotinine levels, with the exception of snuff 
usage in late pregnancy [44,177]. We therefore abstained from using the snuff information in 
late pregnancy in Study III. 
The perinatal outcomes were all retrieved from the MBR and consequently measured and 
reported by health care professionals at the time of measurement, ensuring high quality data. 
Our measures of asthma have been validated in a previous study, which indicated a high 
validity in the older children (> 4.5 years) for both asthma based on medication only and 
asthma based on doctor’s diagnosis only, while the validity was lower for asthma based on 
medications only in the younger children [166]. In the younger group, we therefore required 
both medication and a doctor’s diagnosis in the NPR to be classified as asthma.  
School performance was retrieved from a national register, with data reported by schools, 
resulting in high quality data. Naturally the choice of grade point average, non-eligibility and 
results from national tests as measures of school performance could be discussed, as they may 
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be influenced by choice of school and parental factors. However, those are likely to be the 
measures of school performance from compulsory school with the highest impact on future 
educational prospects. 
5.1.4 Confounding 
Confounding is a central issue in all observational research. In Studies I and II we used the 
common approach of adjusting for measured confounders in regression models, consequently 
we could not preclude that our results are biased due to residual confounding. Indeed, in 
Study II where we complemented this approach by the use of E-values, we saw that the 
findings could potentially be explained by residual confounding. We could also see from 
bivariate analyses that a woman’s SDP was associated with a 40% increased risk of her 
daughter-in-law being born SGA, i.e. a stronger association than that with her grandchild 
being born SGA, despite no biological relation. This can only be explained by confounding, 
including factors influencing choice of spouse. Taken together those results were strong 
indications of residual confounding explaining the paternal grandmother’s SDP – grandchild 
SGA association in Study II. Similarly, we could suspect residual confounding also in the 
associations with maternal grandmother’s SDP. In study III and IV we used sibling 
comparisons to account for unmeasured familial confounding that is shared between siblings, 
in addition to adjustment for measured confounders, as a way to partly address the issue of 
residual confounding. When accounting for those familial factors most of the estimates were 
close to null in both studies, indicating the importance of taking familial factors into account 
in studies like these, where socioeconomic and lifestyle factors may be important 
confounders. 
5.1.5 Sibling design 
Although sibling design has some strong advantages, it also comes with some limitations. 
One limitation that has already been mentioned in section 6.1.3 is the sensitivity to 
measurement error or misclassification of the exposure variable, which is a more serious 
problem in sibling design than in ordinary epidemiological designs. This usually leads to 
attenuation of the estimates and can therefore be a potential explanation for null findings, 
which ought to be considered.  
Another limitation that may lead to underestimation of associations is the fact that we, in 
sibling designs, not only adjust for shared confounders, but also for shared mediators. What 
we estimate is in other words not the total effect, but the direct effect that is not explained by 
causal pathways via shared mediators. In Study III, where we estimated the association 
between SDP and asthma/wheeze, ETS in the household was a mediator that we adjusted for, 
as far as it was shared between siblings. Thus, we cannot be sure the attenuation was due to 
adjustment for shared confounders. The explanation may also be adjustment for ETS and 
other shared mediators.  
Related to this is the loss of power in sibling designs, due to the fact that pairs only contribute 
to the effect estimates to the extent that they are discordant in the exposure. Sibling pairs 
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sharing exposure will only contribute indirectly and very little to the estimates. As a result, 
the confidence intervals for the sibling analyses were wide in Study III and likewise for the 
estimated associations between severe uncontrolled asthma and non-eligibility to USS in 
Study IV. 
A fourth limitation stems from cross-over effects between siblings. This was also a potential 
issue in Study III. If a child gets asthma the parents should be advised to refrain from 
smoking. Consequently, if a child in a family gets asthma and the parents follow the 
recommendation to refrain from smoking this would affect the exposure of the foetus in a 
subsequent pregnancy. The assumption of no such cross-over effect is not testable. However, 
we estimated the risk of SDP if an older sibling had asthma compared to if the older sibling 
did not have asthma. It turned out that the mothers of the children with asthma were actually 
more likely to smoke in the next pregnancy compared to the other mothers. There is likely to 
be residual confounding affecting this estimate, but at least it indicates that it is unlikely that 
there would be a strong tendency towards refraining from SDP when an older child has 
asthma. Although this is a potential health issue for children with asthma, it was reassuring 
for our analyses.  
5.2 FINDINGS 
5.2.1 Study I 
In Study I we could not replicate previous findings of associations between salivary cortisol 
and subjective measures of distress and likewise between salivary cortisol and perinatal 
outcomes. We also found little evidence of associations between subjective measures of 
distress and perinatal outcomes, with the possible exception of associations between 
subjective measures of distress and BW by GA and sex (BW Z-scores). However, the 
associations were weak and the direction was contrary to much of the previous research 
[77,78,81,82]. Thus, our results indicate no negative influence of maternal stress on perinatal 
outcomes. As a consequence of those results no mediation analysis could be performed. 
A question that arises is why we did not replicate previous findings. Regarding associations 
between subjective measures of distress and cortisol levels in pregnancy, statistically 
significant associations have been found in several [27-36], but not all [37-41] studies.  
One reason why results differ between studies and between our study and many others, may 
be differences in study populations. This has been seen in meta-analyses on distress and 
perinatal outcomes. One meta-analysis study showed that associations were weaker in studies 
from the United States and “European social democracies” compared to developing countries 
[79] and another study found stronger associations among women of lower socioeconomic 
background [78]. There may also be differences between studies with and without adjustment 
for confounders and between studies of different quality [78,79,81]. 
Another reason for differences in results may be choice of distress measures. Although a 
meta-analysis study found evidence of an association between distress and perinatal 
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outcomes [76], the results may be different when focusing on one particular measure of 
distress. Thus, we have found seven studies, with sample sizes varying between 92 and 865, 
investigating the PSS-10 or PSS-14 at different stages of pregnancy, in relation to birth 
weight. Most of those found no statistically significant associations with birth weight, 
preterm birth, GA or SGA, with point estimates pointing in different directions [34,37,178-
180], with the exception of one study finding an association with SGA [181] and one finding 
associations with both preterm birth and LBW [182].  
Several studies have found significant results for associations between salivary cortisol and 
perinatal outcomes [27,28,36-38,40,83-89]. In a review of the literature on maternal antenatal 
cortisol levels and child outcomes, Zijlmans et al [22] noted that most statistically significant 
estimates showed the same direction. However, a majority of the included studies did not find 
statistically significant associations and those who did had not adjusted for confounders.  
5.2.2 Study II 
In Study II we saw that the grandchildren of maternal grandmothers who smoked during 
pregnancy had an approximately 30% higher risk of being born LGA. In contrast the 
grandchildren of paternal grandmothers who smoked during pregnancy had approximately 
30% higher risk of being born SGA. A small part of the association with maternal 
grandmothers’ SDP seemed to be explained by the daughters of the grandmothers who 
smoked being more likely to be obese, while a small part of the association with paternal 
grandmothers’ SDP seemed to be explained by their daughters-in-law being more likely to 
smoke during pregnancy. However, the e-values were low, in particular for the indirect 
effects, which indicated that residual confounding may explain the associations. 
Our results for the total effects are in line with most previous research on maternal 
grandmaternal SDP and offspring intrauterine growth [98-101], but not all [96,97]. Only two 
previous studies have published results for paternal grandmothers’ SDP, with point estimates 
in opposite directions, depending on whether the mother smoked or not during pregnancy 
[97,98]. Our results for paternal grandmothers’ SDP were in line with those for children of 
mothers who smoked [97]. The novelties with our study were the focus on SGA and LGA 
rather than BW, the mediation analysis and sensitivity analysis for unmeasured confounding. 
Those results could not be compared to previous research.  
5.2.3 Study III 
In Study III the results indicated an association between SDP and asthma/wheeze in the first 
two years of life and possibly an association between snuff use during pregnancy and 
asthma/wheeze in a time window around 1-2 years of age. However, the sibling comparisons, 
which account for all confounders and mediators that are shared within the sibling pairs, did 
not show an increased risk of asthma/wheeze for the siblings exposed to SDP. 
Our results are in line with a meta-analysis study finding an association between SDP and 
early wheeze in the child [183]. In the same study they also found an association between 
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ETS and early wheeze, for both prenatal and postnatal ETS. Some studies have separated 
SDP only, maternal postnatal smoking only, and both SDP and postnatal smoking, with 
mixed results for the association with offspring asthma/wheeze. Three studies found stronger 
associations with SDP only, than for postnatal smoking only, but also compared to exposure 
to both SDP and postnatal smoking [52,184,185], while one study found no difference [186]. 
Other studies found ORs for asthma or wheeze that were higher for postnatal smoking than 
for SDP, with or without the other [187,188], while one study found somewhat higher 
estimates for SDP only compared to ETS with or without SDP [189]. In our study we did not 
have information on maternal postnatal smoking or other ETS. However, the sibling 
comparison accounts for environmental confounders and mediators that are shared by the 
siblings, including ETS if both siblings were exposed. 
Although others have found an association between Swedish moist oral snuff use in 
pregnancy and neonatal apnea [63], suggesting an influence of intrauterine exposure to 
nicotine on the respiratory system, we found no consistent association between snuff use and 
asthma/wheeze. In combination with results from our sibling analyses on SDP, those results 
suggest a limited role of prenatal exposure to nicotine in the development of asthma/wheeze.  
5.2.4 Study IV 
In Study IV we investigated school performance in children with and without asthma and the 
role of asthma severity and control. We found that most differences were likely to be 
explained by genetics and family environment. However, children with severe but controlled 
asthma in Grades 7-8 may perform slightly better in school than children without asthma, 
while having uncontrolled asthma in Grade 9 may lead to worse school performance 
compared to children without asthma.  
A majority of previous studies have shown lower school performance in children with asthma 
compared to children without [136,190-196]. Other studies have had null findings or showed 
better performance among the children with asthma [197-202]. One possible reason for 
diverging results could be differences in asthma phenotypes, as we saw different results by 
asthma severity and control. Another possible reason is that most studies have had a mix of 
children of different ages, from primary school children to adolescents in upper secondary 
school [190,191,193,196,198,200,201,203]. According to Tsakiri et al children with asthma 
had lower grades than their peers in elementary school, but not in middle school [196]. Two 
smaller Swedish studies have compared grades from Grade 9 by asthma status, with one 
finding that children with asthma had lower grades [136] and one finding no difference [197].  
Similar to us, an American sibling study from 1992, including 101 asthma discordant sibling 
pairs, found no difference in reading, mathematics and composite achievement between the 






From the four studies included in this thesis we could draw the following conclusions: 
 Based on the MAESTRO cohort we found small and statistically non-significant 
associations between salivary cortisol measures, concurrent measures of subjective 
distress and the perinatal outcomes BW, BL, BW Z-scores and GA, with the 
exception of a small but statistically significant association between worse subjective 
distress and higher BW Z-scores. Timing of stress measurement did not seem to 
matter. 
 We saw a somewhat increased risk of LGA among children whose maternal 
grandmothers smoked during pregnancy, with an indication of a small part of the 
association being explained by maternal obesity. Likewise, we found a slightly 
increased risk of SGA in children whose paternal grandmother smoked during 
pregnancy, with a small part possibly explained by their own mothers’ SDP. 
However, sensitivity analyses indicated that most of the results could be due to 
residual confounding. 
 We also found that children of mothers who smoked during pregnancy were at higher 
risk of asthma/wheeze in the first two years of life. Nicotine seemed to have a limited 
role in this association, while unmeasured confounding and mediating factors shared 
among siblings seemed to play an important role for the association. 
 Children with severe asthma did not seem to have lower school performance than 
children without asthma, if the asthma was controlled. For children with uncontrolled 
asthma the picture was more complicated. Familial factors seem to explain the 
negative associations with asthma in Grades 7-8, but not Grade 9. However, we 
cannot rule out residual confounding by factors associated with both asthma treatment 
adherence and school performance. 
The results of the four studies included in this thesis have mostly shown very modest 
associations or associations that were likely to be explained by residual confounding or 
confounding by familial factors rather than being causal. However, other studies have found 
maternal stress, worry, depressive symptoms, and bad sleep quality to be associated with 
negative outcomes for both the unborn child and the mother [17,18,22]. SDP is believed to 
cause many serious adverse health effects for both the mother and the unborn child 
[45,46,51]. If a child’s asthma is uncontrolled the child may experience worse respiratory 
problems in the future, be unable to participate in activities as other children and in the worst 
case suffer a life-threatening asthma exacerbation. Thus, the results of the studies of this 
thesis should not in any way be interpreted as excuses for ignoring stress in pregnant women, 





7 FUTURE PERSPECTIVES 
Although we found very weak evidence of an association between distress, cortisol levels and 
perinatal outcomes, in contrast to many other studies. Further research is needed to fully 
understand the effects of distress on the foetus. Are there certain types of distress that are 
associated with perinatal outcomes? What is the biological mechanism? If prolonged stress is 
more important than temporary stress, cortisol measurements taken from hair which reflects 
cortisol levels over longer periods could be a better mediator candidate than salivary cortisol 
[204,205]. Hair cortisol also has the advantage of allowing for tracing back in time and 
moreover, the sampling procedure is easy and non-invasive. Potential mediators are also 
other stress hormones, e.g. corticotrophin-releasing hormone or adrenocorticotrophic 
hormone and maternal factors that are causes or consequences of distress.  
The intergenerational effects of SDP on intrauterine growth seem to be small, but may merit 
continued elucidation to better understand the potential dangers of tobacco smoke exposure. 
Considering the potential influence by unmeasured confounding, family-based designs may 
further the understanding of the underlying mechanisms. 
Electronic cigarettes are a new form of nicotine exposure and the prevalence of regular use 
among young adults has been estimated to 3-4% in Sweden [206] and the United States 
[207]. Considering that some women are likely to continue vaping during pregnancy, the role 
of prenatal exposure to electronic cigarettes is an important area of research. However, in 
absence of vaping information in registers, such as the MBR, large cohort studies would be 
necessary to study potential risks for the foetus. In Study III, we used Swedish moist oral 
snuff to study nicotine exposure in utero. Nicotine is an important toxin from electronic 
cigarettes, although not the only one [208], thus snuff could be a feasible exposure alternative 
to electronic cigarette use during pregnancy in epidemiological research.  
Although our results from Study IV were reassuring regarding negative effects from asthma 
on school performance, we could not rule out a potentially detrimental effect of uncontrolled 
asthma. It would therefore be valuable to better understand if the estimates were confounded 
by factors not shared by siblings. In particular it would be valuable to study how personal 
characteristics influence teenagers’ treatment adherence and whether those factors affect 
school performance. Examples of characteristics that could be of interest are symptoms of 
psychiatric or neurodevelopmental disorders, forgetfulness, sensitivity to peer pressure and 
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